Pharmaceuticals News and Research

RSS

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Shire plc, the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy (ERT) for the potential treatment of both the central nervous system (CNS) and somatic manifestations in patients with Hunter syndrome (MPS II).

23 Jul 2014

Sinovac selected to supply seasonal influenza vaccine to Beijing citizens

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention to be a supplier of the seasonal influenza vaccine to the citizens of Beijing for 2014.

23 Jul 2014

Iowa researchers develop vaccine to combat dust-mite allergies

Researchers at the University of Iowa have developed a vaccine that can combat dust-mite allergies by naturally switching the body's immune response.

23 Jul 2014

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Gaston Picchio outlines the major findings of the recent report published by The Economist Intelligence Unit (EIU): ‘Tackling hepatitis C: Moving towards an integrated policy approach’

23 Jul 2014

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

23 Jul 2014

Novasep becomes authorized producer of new molecular entity for US market

Novasep, a leading supplier of services and technologies to the life science industries, today announces that it has successfully completed FDA (US Food and Drug Administration) pre-approval inspections carried out at two of its sites in France.

23 Jul 2014

Glide Pharma announces successful completion of pre-clinical proof-of-concept study with novel solid formulation of octreotide acetate

Glide Pharma, the pharmaceutical development and device company focused on solid dose formulations of therapeutics and vaccines, today announced that its novel solid formulation of octreotide acetate achieved successful results in a pre-clinical proof-of-concept study comparing it with the currently marketed liquid product (Sandostatin®).

22 Jul 2014

First Edition: July 22, 2014

Reporting for Kaiser Health News, Susan Jaffe writes: "Medicare officials have allowed patients at dozens of hospitals participating in pilot projects across the country to be exempted from the controversial requirement that limits nursing home coverage to seniors admitted to a hospital for at least three days.

22 Jul 2014

Researchers prove that CD27 drug is true alternative against malaria

Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria.

22 Jul 2014

NuAire's Laminar Airflow Workstations create bacteria-free, clean air environment

NuAire's AireGard ES NU-201 Table Top and NU-301 Console Horizontal Laminar Airflow Hoods provide a HEPA filtered clean work area that is ideal for operations requiring a particle-free, bacteria-free, clean air environment.

22 Jul 2014

New poll finds consumers have trouble comparing physicians' quality of care

Americans consider insurance and a good bedside manner in choosing a doctor, but will that doctor provide high-quality care? A new poll shows that people don't know how to determine that. Being licensed and likable doesn't necessarily mean a doctor is up to date on best practices. But consumers aren't sure how to uncover much more. Just 22 percent of those questioned are confident they can find information to compare the quality of local doctors, according to the poll by The Associated Press-NORC Center for Public Affairs Research (7/20).

22 Jul 2014

Cost of Sovaldi and other specialty drugs worries states, pharmaceutical executives

News outlets continue to examine how Solvadi - usually an expensive cure for hepatitis-C - might affect budgets.

22 Jul 2014

CFDA approves CASI's ENMD-2076 Phase II trial in triple-negative breast cancer patients

CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that China's Food and Drug Administration has approved the Company's application to conduct a Phase II clinical trial in triple-negative breast cancer (TNBC) patients in China for its proprietary drug candidate, ENMD-2076.

21 Jul 2014

First Edition: July, 21, 2014

Today's headlines include a story about an effort by regulators to widen insurer networks, as well as a range of other health policy developments.

21 Jul 2014

Scientist uses samples of beating heart tissue to test effect of drugs

A Coventry University scientist has developed a pioneering new way - using samples of beating heart tissue - to test the effect of drugs on the heart without using human or animal trials.

21 Jul 2014

New material can extract atoms of rare or dangerous elements from air

Scientists at the University of Liverpool have successfully tested a material that can extract atoms of rare or dangerous elements such as radon from the air.

21 Jul 2014

National Med Care partners with Taking You Forward for marketing pharmaceutical products in the U.S.

Richmond Private Equity Group Limited announced today that its "portfolio company", National Med Care Ltd, a Salt Lake City Utah, based pharmaceutical marketing firm has entered into an agreement with Taking You Forward Inc., a Cebu Philippines based BPO firm to form a joint venture for the marketing of its compound pharmaceutical products in the United States.

18 Jul 2014

Phase 3 VIVID-DME trial of EYLEA Injection for treatment of DME shows improvement in visual acuity

Regeneron Pharmaceuticals, Inc. today announced that in the Phase 3 VIVID-DME trial of EYLEA® (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100 (2 years), compared to laser photocoagulation.

18 Jul 2014

PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014" report

PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014", is now available for free download. The report explores one of Europe's largest pharma markets, and looks at the delicate balance between a strong and growing economy, and healthcare legislation that many complain is negatively affecting the pharmaceutical market.

17 Jul 2014

Glenmark plans to set up new manufacturing facility at Monroe Corporate Center, USA

Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company, plans to set up a new manufacturing facility in the US.

17 Jul 2014

Pharmaceuticals News and Research

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Sinovac selected to supply seasonal influenza vaccine to Beijing citizens

Iowa researchers develop vaccine to combat dust-mite allergies

Tackling hepatitis C: an interview with Gaston Picchio, Global Hepatitis Disease Area Leader at Janssen

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

Novasep becomes authorized producer of new molecular entity for US market

Glide Pharma announces successful completion of pre-clinical proof-of-concept study with novel solid formulation of octreotide acetate

First Edition: July 22, 2014

Researchers prove that CD27 drug is true alternative against malaria

NuAire's Laminar Airflow Workstations create bacteria-free, clean air environment

New poll finds consumers have trouble comparing physicians' quality of care

Cost of Sovaldi and other specialty drugs worries states, pharmaceutical executives

CFDA approves CASI's ENMD-2076 Phase II trial in triple-negative breast cancer patients

First Edition: July, 21, 2014

Scientist uses samples of beating heart tissue to test effect of drugs

New material can extract atoms of rare or dangerous elements from air

National Med Care partners with Taking You Forward for marketing pharmaceutical products in the U.S.

Phase 3 VIVID-DME trial of EYLEA Injection for treatment of DME shows improvement in visual acuity

PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014" report

Glenmark plans to set up new manufacturing facility at Monroe Corporate Center, USA

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence